共 50 条
- [1] Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care [J]. HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2024, 16 : 133 - 140
- [3] Two-Drug Regimen for HIV [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (19): : 1862 - 1862
- [4] Dolutegravir/Lamivudine (Dovato) - A Two-Drug Complete Regimen for HIV-1 Infection [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1579): : 134 - 136
- [7] REAL WORLD EXPERIENCE WITH DOLUTEGRAVIR-BASED TWO-DRUG REGIMENS [J]. VALUE IN HEALTH, 2019, 22 : S195 - S195
- [9] HIV Treatment with the Two-Drug Regimen Dolutegravir Plus Lamivudine in Real-world Clinical Practice: A Systematic Literature Review [J]. Infectious Diseases and Therapy, 2021, 10 : 2051 - 2070